Chief Executive Officer
CurrentRCC is the JV between Restem Biotech inc, and the Cell Surgical Network HQ'd in California,USA Founded by Dr Mark Berman and Dr Elliott Lander. With HQ's in Suzhou, and laboratories and Health Centers across mainland China, RCC is in a unique position to quickly spread the latest in Autologous Cellular Therapies, Early Cancer Detection and Cardiopulmonary disorder testing. Currently we are well established in Suzhou, Shanghai, Beijing, & Shenzhen with plans to IPO in 2019.